Ad
CPRX Quote Trading Chart Catalyst Pharmaceuticals Inc.
home / stock / cprx / cprx quote
$12.97 Last:
24.71% Change Percent:
$13.1 Open:
$10.40 Previous Close:
$13.1 High:
$12.66 Low:
294,429 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CPRX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-11 | 13.1 | 10.4 | 13.1 | 12.66 | 294,429 |
| 2022-08-10 | 11.97 | 10.4 | 13.24 | 11.61 | 4,075,361 |
| 2022-08-09 | 10.79 | 10.4 | 10.96 | 10.54 | 1,926,030 |
| 2022-08-08 | 11.31 | 10.4 | 11.32 | 10.67 | 2,250,744 |
| 2022-08-05 | 10.62 | 10.4 | 11.17 | 10.5 | 2,406,668 |
| 2022-08-04 | 10.5 | 10.4 | 10.91 | 10.45 | 1,388,530 |
| 2022-08-03 | 10.65 | 10.4 | 10.87 | 10.48 | 1,040,047 |
| 2022-08-02 | 10.27 | 10.4 | 10.77 | 10.245 | 1,878,035 |
| 2022-08-01 | 10.2 | 10.4 | 10.53 | 10.04 | 1,232,768 |
| 2022-07-29 | 10.6 | 10.4 | 10.71 | 10.11 | 1,386,745 |
| 2022-07-28 | 10.4 | 10.4 | 10.72 | 10.18 | 1,686,627 |
| 2022-07-26 | 9.83 | 9.83 | 10.17 | 9.68 | 1,557,687 |
| 2022-07-25 | 9.57 | 9.92 | 10.01 | 9.54 | 4,359,552 |
| 2022-07-19 | 8.68 | 9.32 | 9.49 | 8.68 | 2,915,592 |
| 2022-07-18 | 8.62 | 8.67 | 9.035 | 8.62 | 1,968,580 |
| 2022-07-15 | 8.53 | 8.57 | 8.595 | 8.2 | 1,406,017 |
| 2022-07-14 | 8.44 | 8.43 | 8.58 | 8.165 | 2,037,954 |
| 2022-07-13 | 7.57 | 8.51 | 8.565 | 7.5113 | 2,349,846 |
| 2022-07-12 | 7.4 | 7.74 | 7.975 | 7.4 | 2,224,390 |
| 2022-07-11 | 7.5 | 7.41 | 7.64 | 7.36 | 1,464,904 |
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
Ad
-
Achieved Record Q2 2022 FIRDAPSE® Net Product Revenues of $53.0 Million, a 57.7% YoY Increase Cash and Short-Term Investments at June 30, 2022 were $220.8 Million, with No Funded Debt Completed Acquisition of Ruzurgi® U.S. and Mexico Commercial Rights...
-
CORAL GABLES, Fla., July 26, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announce...
-
CORAL GABLES, Fla., July 12, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announce...
Ad
Important Investor News Alert (OTCMKTS: GTCH)
-
SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT” or the “Company”), filed a second continuation patent application for its 3D, Multi-Planar IC design and manufacturing technology application, focusing on memory mi...